Valiant Organics Limited (BOM:540145)
India · Delayed Price · Currency is INR 325.75
-17.10 (-4.99%)
At close: Aug 14, 2026
Valiant Organics Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 7,681 | 7,388 | 7,188 | 7,231 | 10,518 | 11,533 |
Revenue Growth | 1.70% | 2.78% | -0.59% | -31.25% | -8.80% | 52.79% |
Gross Profit Gross Profit Growth | 3,228 | 3,014 | 2,442 | 2,152 | 3,420 | 3,588 |
Operating Income Operating Income Growth | 667.63 | 486.12 | 177.76 | 29.09 | 1,356 | 1,762 |
Net Income Net Income Growth | 540.85 | 332.36 | -37.36 | -83.91 | 881.21 | 1,133 |
Earnings Per Share EPS Growth | 19.33 | 11.86 | -1.35 | -3.07 | 31.50 | 40.51 |
EPS Growth | 1055.02% | - | - | - | -22.24% | -1.12% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Speciality Chemicals Speciality Chemicals Growth | 5,748 | 7,188 | 7,231 | 10,518 | 11,533 |
Pharma Pharma Growth | 1,639 | - | - | - | - |
Total Total Growth | 7,388 | 7,188 | 7,231 | 10,518 | 11,533 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 21.43 | 21.43 | 76.06 | 70.59 | 456.71 | 499.47 |
Total Debt Total Debt Growth | 2,559 | 2,559 | 2,488 | 2,570 | 2,737 | 3,634 |
Net Cash (Debt) Net Cash Growth | -2,538 | -2,538 | -2,412 | -2,500 | -2,280 | -3,135 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -90.69 | -90.55 | -87.38 | -91.58 | -81.50 | -112.10 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 919.9 | 564.32 | 839.97 | 2,379 | -307.47 |
Capital Expenditures CapEx Growth | - | -335.33 | -308.29 | -749.3 | -1,517 | -1,227 |
Free Cash Flow Free Cash Flow Growth | - | 584.58 | 256.03 | 90.67 | 862.19 | -1,534 |
Free Cash Flow Growth | - | 128.32% | 182.39% | -89.48% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 42.02% | 40.80% | 33.97% | 29.76% | 32.51% | 31.12% |
Operating Margin | 8.69% | 6.58% | 2.47% | 0.40% | 12.89% | 15.27% |
Pretax Margin | 8.80% | 5.68% | 0.30% | -1.20% | 13.04% | 15.28% |
Profit Margin | 7.04% | 4.50% | -0.52% | -1.16% | 8.38% | 9.82% |
FCF Margin | - | 7.91% | 3.56% | 1.25% | 8.20% | -13.30% |
| Fiscal Year | FY 2023 | FY 2022 |
|---|---|---|
| Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 3.500 |
Dividend Per Share Growth | -71.43% | -30.00% |
Dividend Yield | 0.24% | 0.38% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.85 | 17.07 | - | - | 12.85 | 22.05 |
Forward PE | - | 10.61 | 10.61 | 10.61 | 10.61 | 14.41 |
P/FCF Ratio | 15.61 | 9.71 | 28.47 | 115.51 | 13.13 | - |
PS Ratio | 1.19 | 0.77 | 1.01 | 1.45 | 1.08 | 2.17 |